Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyperTET: Trabectedin + Regional Hyperthermia in Soft-tissue Sarcoma
NCT02359474Phase 2Unknown
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Dec 2014
- Primary completion
- Aug 2023
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in soft tissue sarcoma (STS), sponsored by Ludwig Maximilian University of Munich. Status: unknown.
02
Drugs
trabectedin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT02359474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359474.